Skip to search formSkip to main contentSkip to account menu

trelagliptin

National Institutes of Health

Related topics

Related topics

4 relations

Narrower (2)

SYR-472trelagliptin succinate

Broader (1)

Uracil
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Randomized Multicenter Evaluation of Quality of Life and Treatment Satisfaction in Type 2 Diabetes Patients Receiving Once-Weekly Trelagliptin Versus a Daily Dipeptidyl Peptidase-4 Inhibitor
IntroductionDipeptidyl peptidase-4 (DPP-4) inhibitors are an established treatment in type 2 diabetes mellitus (T2DM). The… 
Review
2019
Review
2019
Changes in medication adherence and unused drugs after switching from daily dipeptidyl peptidase-4 inhibitors to once-weekly trelagliptin in patients with type 2 diabetes.
2018
2018
Efficacy and safety of trelagliptin in combination with insulin therapy in Japanese patients with type 2 diabetes: Results from a randomized, Phase IV study
We aimed to explore the efficacy and safety of once‐weekly trelagliptin 100 mg as an add‐on therapy to insulin in Japanese… 
Review
2018
Review
2018
Weekly Versus Daily Dipeptidyl Peptidase 4 Inhibitor Therapy for Type 2 Diabetes: Systematic Review and Meta-analysis
Once-weekly dipeptidyl peptidase 4 inhibitors (weekly DPP-4is) were recently developed in addition to the once-daily agents (1… 
2017
2017
Efficacy and safety of once‐weekly oral trelagliptin switched from once‐daily dipeptidyl peptidase‐4 inhibitor in patients with type 2 diabetes mellitus: An open‐label, phase 3 exploratory study
Trelagliptin, a novel once‐weekly oral dipeptidyl peptidase‐4 (DPP‐4) inhibitor, has shown favorable efficacy and safety in type… 
2017
2017
Effect of Trelagliptin on Quality of Life in Patients with Type 2 Diabetes Mellitus: Study Protocol
IntroductionLong-term glycemic control in type 2 diabetes is critical to prevent or delay the onset of macrovascular and… 
2016
2016
Identification, characterization and HPLC quantification of process-related impurities in Trelagliptin succinate bulk drug: Six identified as new compounds.
2015
2015
[Current status of clinical development of novel anti-diabetic drugs].
Clinical development of novel antidiabetic drugs, such as GK activator, GPR40 agonist, GPR119 agonist, 11β-HSD1 inhibitor and… 
2015
2015
Succinic acid trelagliptin orally-disintegrating tablets and preparing method thereof
The invention discloses succinic acid trelagliptin orally-disintegrating tablets and a preparing method thereof. The orally… 
2013
2013
New solid forms of trelagliptin and manufacturing method and purpose thereof
The invention relates to six new solid forms of a dipeptidyl peptidase IV inhibitor, trelagliptin, a manufacturing method of the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)